MAP1LC3A and neuroblastoma: Based on H&E staining, we found that CTL shRNA plasmid transfection and LC3 shRNA plasmid transfection groups maintained almost similar growth of malignant neuroblastoma xenografts, GST treatment group exhibited cell death to some extent, and combination of LC3 shRNA plasmid transfection and GST treatment prominently inhibited cell growth and induced cell death in both malignant neuroblastoma SK-N-BE2 and IMR-32 xenografts.